The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL). Sharplin KM, Marks DI. Leuk Lymphoma 2022;63:1292-1301.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sharplin KM, Marks DI. The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL). Leuk Lymphoma 2022;63:1292-1301.
PMID: 34991420